Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):330–341. doi: 10.1097/QAI.0000000000001925

Table 3.

Predictors of 30-day Readmissions: Univariate Analyses

Variable Unadjusted OR (95% CI) P value
Demographics
Age 1.01 (0.99, 1.03) 0.37
Male gender 0.88 (0.60, 1.29) 0.50
Race/ethnicity
 Hispanic/other v non-Hispanic white
 Non-Hispanic Black v non-Hispanic white

0.59 (0.27,1.28)
0.88 (0.51, 1.52)

0.18
0.66
HIV Risk factor
 IDU v MSM
 Heterosexual v MSM

1.50 (0.82, 2.75)
1.93 (1.10, 3.38)

0.18*
0.02*
Marital status
 Married/living together v other

1.21 (0.69, 2.10)

0.50
Treatment group
 PN-CM v. PN
 TAU v. PN

0.74 (0.48,1.15)
0.76 (0.49, 1.19)

0.18
0.23
Socio-economic
Education
 High school or greater

1.07 (0.75, 1.55)

0.74
Income, annual
 <$10,000/year v other**

1.84 (1.07, 3.16)

0.03*
Insurance
 Any
 Medicaid^

1.43 (0.95, 2.15)
1.86 (1.29, 2.68)

0.09*
0.001*
Employment
 Disabled v working
 Other v working

2.16 (1.04, 4.49)
2.07 (0.98, 4.36)

0.04*
0.06*
Food insecurity,
 Moderate-severe v none/mild

1.79 (1.23, 2.59)

0.002*
Housing
 Homelessness

1.03 (0.63, 1.71)

0.89
Socio-behavioral
Prior Incarceration, any
 Past 6 months
1.18 (0.75, 1.85)
0.93 (0.55, 1.56)
0.48
0.78
Substance use (past 12 months)
 Simulants
 Opiates
 Polysubstance use (≥2)

1.17 (0.78, 1.76)
1.00 (0.64, 1.55)
0.83 (0.58, 1.20)

0.44
0.99
0.33
Substance use
 AUDIT
 DAST-10
 Severe substance use (AUDIT or DAST-10)

1.04 (0.72, 1.50)
1.02 (0.71, 1.48)
0.96 (0.65, 1.40)

0.85
0.91
0.82
Substance use treatment attitudes
 Readiness
 Negative attitude

0.97 (0.94, 1.00)
0.98 (0.93, 1.03)

0.06*
0.51
Smoking 0.84 (0.56, 1.26) 0.40
Adherence to antiretrovirals
 Taking >85%

1.14 (0.71, 1.83)

0.58
Adherence self-efficacy
 Integration
 Perseverance
 Total score

0.99 (0.99, 1.00)
0.99 (0.97, 1.02)
0.99 (0.99, 1.00)

0.54
0.46
0.46
Patient provider relationship (N=548) 1.00 (0.99,1.01) 0.85
Medical mistrust 1.01 (0.99, 1.04) 0.30
Health literacy 0.96 (0.91, 1.01) 0.12*
Perceived health status 0.98 (0.96, 1.00) 0.06*
Interpersonal violence 1.41 (0.94, 2.12) 0.10
Psychological distress (BSI)
 Anxiety/panic
 Somatization
 Depression
 Any

1.15 (0.80, 1.66)
0.98 (0.68, 1.42)
1.36 (0.94, 1.96)
1.36 (0.94, 1.97)

0.45
0.93
0.10
0.11
Social support 1.00 (0.98, 1.03) 1.00
Access to care 1.00 (0.97, 1.05) 0.73
Distance from hospital
 >13 miles from hospital
0.99 (0.97, 1.01)
0.63 (0.32, 1.25)
0.27
0.19
Hospitalization details
Length of stay 1.03 (0.97, 1.03) 0.97
Primary diagnosis on admission
 AIDS defining illness
 Infection, non AIDS defining
 Cardiovascular
 Gastrointestinal/Liver
 Neurology
 Psychiatry
 Pulmonary
 Substance use

1.18 (0.65, 2.14)
0.85 (0.58, 1.24)
1.97 (1.11, 3.52)
1.90 (1.22, 3.23)
0.80 (0.35, 1.81)
1.71 (0.61, 4.83)
0.56 (0.29, 1.08)
1.59 (0.43, 5.94)

0.59
0.40
0.02*
0.02*
0.59
0.31
0.09*
0.49
On ART prior to admission 1.33 (0.92, 1.93) 0.13
Started on ART during admission 1.23 (0.76, 2.00) 0.39
Discharged with supply of ART 0.88 (0.54, 1.43) 0.60
Referrals received as inpatient
 Case management
 Drug treatment
 Housing
 Mental health
 Outpatient HIV clinic
 Any referral

0.68 (0.43, 1.11)
0.74 (0.43, 1.27)
0.68 (0.38, 1.24)
1.10 (0.58, 2.07)
0.94 (0.65, 1.36)
0.88 (0.60, 1.30)

0.12*
0.27
0.21
0.77
0.75
0.52
Laboratory values/illness severity
CD4 count, cells/uL
 <50 v. >200
 50–200 v. >200

1.68 (1.09, 2.60)
0.93 (0.57, 1.50)

0.02*
0.76
HIV viral load (log)
 Undetectable <200 v other
0.99 (0.94, 1.05)
1.27 (0.73, 2.20)
0.81
0.40
HCV Ab status (N=559) 1.07 (0.68, 1.70) 0.77
Laboratory values
 WBC < 4.2 × 10(9)/L
 Absolute lymphocytes < 1.3 × 10 (9)/L
 HCT <39.6% (men), <34.1% (women)
 Creatinine <0.67(mg/dL)
 Creatinine> 1.17 (mg/dL)
 AST > 50 U/L (men) or >35 U/L (women)
 ALT > 50 U/L (men) or >35 U/L (women)

1.88 (1.00, 3.53)
0. 69 (0.50, 0.97)
0.96 (0.93, 0.99)
1.25 (0.74, 2.09)
1.59 (1.06, 2.38)
1.00 (0.99, 1.00)
1.00 (0.99, 1.00)

0.05*
0.03*
0.01*
0.41
0.02*
0.99
0.86
HIV-dementia scale (<= 10) 1.41 (0.95, 2.10) 0.09*
Karnofsky <80 1.45 (1.01, 2.09) 0.05*
Healthcare utilization
HIV primary care visit in past 6 months 1.08 (0.75, 1.56) 0.68
ED visits in past 12 months
 ≤1
 2–4
 >= 5

Ref
2.26 (1.43, 3.58)
4.01 (2.40, 6.71)

--
<0.001*
<0.001*
Hospitalizations in past 6 months
 0
 1
 ≥2

Ref
2.3 1(1.41, 3.76)
3.60 (2.28, 5.67)

--
<0.001*
<0.001*
**

missing included in low income category

^

includes dual insurance (Medicare + Medicaid)

*

p value ≤ 0.20

IDU= injection drug use; MSM= men who have sex with men; PN-CM= patient navigation with contingency management; PN= patient navigation; TAU= treatment as usual;AUDIT= alcohol use disorders identification test; DAST-10= drug abuse screening test; SD= standard deviation; BSI=brief symptom inventory; AIDS= acquired immune deficiency syndrome; ART= antiretroviral therapy; HCV Ab=hepatitis C virus antibody; WBC= white blood cell count; HCT= hematocrit; AST= aspartate aminotransferase; ALT= alanine aminotransferase; ED= emergency department